Legend Biotech(us:LEGN)

33.93

-3.22%

Updated on 2025-03-31

Open:33.98
Close:33.93
High:34.41
Low:32.85
Prev Close:35.06
Volume:1.27M
Turnover:42.70M
Turnover Ratio:0.69%
Shares:183.65M
MarketCap:6.23B

About Legend Biotech

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Company Name: Legend Biotech
Address: 2101 Cottontail Lane
Employees: 1826
Fiscar Year: 12-31
IPO Date: 2020-06-05
CIK: 1801198

View all SEC Filings

About

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.
Address:2101 Cottontail Lane

Market Movers